Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

60%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

2(40.0%)

N/A

2(40.0%)

Phase 4

1(20.0%)

5Total

Phase 3(2)

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT02387385Not ApplicableCompleted

Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial

Role: collaborator

NCT02551536Phase 4Completed

Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis

Role: lead

NCT01386840Not ApplicableCompleted

IndiaCLEN Multicentre Trial of Home Versus Hospital Oral Amoxicillin for Management of Severe Pneumonia in Children

Role: collaborator

NCT01593306Phase 3Unknown

Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix

Role: lead

NCT01440621Phase 3Completed

Modafinil in Cancer Related Fatigue

Role: lead

All 5 trials loaded